Weekly Top Biotech & Medical Business Articles
From BioHealth Investor The following articles were the most popular at BioHealth Investor for the week of February 17 – February 23. 1. Novadel Drops After Zensana Launch Delayed by Hana Biosciences 2. Acorda therapeutics: Pipeline Does Not Support Valuation…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
From BioHealth Investor
The following articles were the most popular at BioHealth Investor for the week of February 17 – February 23.
1. Novadel Drops After Zensana Launch Delayed by Hana Biosciences
2. Acorda therapeutics: Pipeline Does Not Support Valuation
3. Merck Pressured to Halt Gardasil Vaccine Lobbying
4. State Healthcare & Pharmaceutical Legislature Roundup
5. Tiny Biosante Could Skyrocket with Estrogen Replacement Gel
http://www.biohealthinvestor.com/
Contact [email protected] for any questions or corrections.